AMBP, alpha-1-microglobulin/bikunin precursor, 259

N. diseases: 150; N. variants: 1
Disease: Hemophilia, NOS ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0684275
Disease: Hemophilia, NOS
Hemophilia, NOS 		0.020 Biomarker disease BEFREE As a result of the new treatment paradigm that the haemophilia community will face with the availability of novel (non-factor) therapies, an updated consensus on ITI recommendations and inhibitor management strategies is needed. 31033112 2019
CUI: C0684275
Disease: Hemophilia, NOS
Hemophilia, NOS 		0.020 Biomarker disease BEFREE Several studies of ITI therapy are ongoing with the aim of clarifying unresolved issues in haemophilia management including the role of von Willebrand factor in inhibitor eradication. 29543371 2018